What smart money is saying about Kyverna Therapeutics
KYTX
No fund has written a full thesis on Kyverna Therapeutics in our archive, but 2 fund letters report a position in it, most recently Jacob Funds Management Commentary in July 2026.
Get an email when a fund buys, sells or pitches it
2
Reported positions
1
Bought
0
Sold
2
Letters
Position history
Every position in Kyverna Therapeutics on record in the archive was reported in Q3 2026, across 2 fund letters, with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 1 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 2 positions · 2 moves
- July 2026
“The Jacob Discovery Fund also added a position in Securitize in the quarter as well as a new position in Kyverna Therapeutics.”
Kyverna Therapeutics - July 2026
“The Jacob Discovery Fund also added a position in Securitize in the quarter as well as a new position in Kyverna Therapeutics.”
Kyverna Therapeutics
Read the letters behind these Kyverna Therapeutics positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger